North America Research Institute-San Dimas — San Dimas, California

North America Research Institute-San Dimas is a clinical research site located in San Dimas, California, United States 91773.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

North America Research Institute-San Dimas has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, ESRD (End-Stage Renal Disease).

Sponsors: Ardelyx, Alebund Pharmaceuticals, Bayer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Dimas

Browse all research sites in California · View every site in San Dimas

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for North America Research Institute-San Dimas?

North America Research Institute-San Dimas has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has North America Research Institute-San Dimas conducted?

North America Research Institute-San Dimas has 6 clinical trials on record, with 4 currently active. Their work covers Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, ESRD (End-Stage Renal Disease).

Is North America Research Institute-San Dimas accredited by Crixeo Clinical Trials?

North America Research Institute-San Dimas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about North America Research Institute-San Dimas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.